Objective: Several cohort studies have shown a link between serum C-reactive protein (CRP) and subsequent cardiovascular disease; however, the role of CRP as an independent risk factor remains controversial. We therefore investigated the association between CRP and sclerotic lesions of common carotid atherosclerosis. 
Introduction
Several epidemiological studies have shown a link between serum C-reactive protein (CRP) and subsequent cardiovascular disease in the general population [1] [2] [3] [4] [5] . Moreover, with respect to carotid atherosclerosis, which is a useful tool to predict the likelihood of cardiovascular disease 6, 7) and is related to many atherosclerotic risk factors 8, 9) , an association between CRP levels and the presence of carotid plaques has been shown in univariate analysis in a prospective survey conducted in the general community (age range, 40 to 79 years) 10) or in healthy middle-aged women with a history of smoking 11) . However, Tracy et al. 12) failed to demonstrate a relationship between CRP and carotid arterial intima-media thickness (IMT) and plaque. Such an association did not remain significant following adjustment for concomitant risk factors for cardiovascular diseases [13] [14] [15] ; thus, the role of CRP as an independent risk factor remains controversial.
The association between CRP and other cardiovascular risk factors complicates this issue. Changes in circulating elevated CRP levels, even within the normal range, are often involved in the interrelation of cardiovascular risk factors, such as age, smoking, obesity, and high blood pressure 16) , all of which play a causal role in the pathogenesis of cardiovascular disease. In Japan, there are studies suggesting a significant relationship between an elevated CRP level and cardiovascular risk factors in a large number of men and women 16) . As such, CRP seems to be merely a graded marker 17) for the effect of certain conventional risk factors on promoting atherogenesis, especially obesity 18) . This study first ascertained the correlation of CRP in a representative sample of inpatients, then demonstrated whether there was an independent association of CRP with the direct and early measurment of carotid IMT by B-mode ultrasonography. To examine these two issues, we used cross-sectional data from participants.
Materials and Methods

Patients
The subjects were inpatients consecutively admitted to the Medical Department of Seiyo Municipal Nomura Hospital between June 2003 and October 2005. Patients with inflammation (CRP 2.0 mg/ dL), severe cardio-renal or nutritional disorders that would affect blood pressure, renal function, lipid and glucose metabolism were excluded. The subjects consisted of 139 men aged 67 15 years and 201 women aged 75 10 years. The reasons for hospitalization were circulatory disorders in 91, diabetes mellitus in 60, respiratory disorders in 45, digestive disorders in 38, neurological disorders other than stroke in 32, urinary or reproductive organ disorders in 16, metabolic disorders in 16, mental disorders in 12, benign neoplasm in 9, joint or bone disorders in 8, skin disorders in 4, hematological disorders in 4, and miscellaneous diseases in 5. Informed consent for the procedure was obtained from each patient. All procedures were approved by the Ethics Committee of Seiyo Municipal Nomura Hospital.
Ultrasound Image Analysis
Ultrasonographic evaluation (Hitachi EUB-565 or Aloka SSD-2000) using a 7.5 MHz linear type B-mode probe was performed by a specialist to evaluate sclerotic lesions of the common carotid arteries on a day close to the day of blood biochemistry analysis (within 2 days). Patients were placed in the supine position, and the bilateral carotid arteries were observed obliquely from the anterior and posterior directions. We measured the thickness of the intima-media complex on the far wall of the bilateral common carotid artery about 10 mm proximal to the bifurcation of the carotid artery (as the image at that site is more clearly depicted compared with that of the near wall) 19, 20) as well as wall thickness near the 10 mm point on the B-mode monitor, and then used the mean value for analysis.
Regarding the measurement of fat thickness by ultrasonographic evaluation (Hitachi EUB-565 or Aloka SSD-2000) using a 7.5 MHz linear type B-mode probe, the subjects were placed in the supine position, the probe was held perpendicular to the skin at the epigastrium, and vertical scanning was performed along the abdominal median from the processus xiphoideus to the umbilicus to measure the maximal thickness of preperitoneal fat (Pmax) at the anterior surface of the liver 21, 22) , and visceral obesity was defined as Pmax 0.8 mm (equal to visceral fat accumulation 100 cm 2 as measured by computed tomography) 23) . Patients with a history of upper abdominal surgery were excluded to avoid any possible effect on the measurement of fat thickness (38 cases).
Metabolic Syndrome
We applied condition-specific cut-off points for metabolic syndrome based on the guidelines for the diagnosis of 'metabolic syndrome' in Japan 24) . Metabolic syndrome was defined as visceral obesity assessed by ultrasonography and at least 2 of the following 3 conditions: hypertension, dyslipidemia (hypertriglycedemia or low HDL cholesterolemia) and impaired fasting glucose.
Various Other Risk Factors
We measured systolic (SBP) and diastolic blood pressure (DBP) in the right upper arm of patients in a seated posture using an automatic oscillometric blood pressure recorder. Height and weight {used to calculate body mass index (BMI) as weight in kilograms divided by the square of height in meters} were measured by standard procedures. Cigarette smoking was quantified based on daily consumption and duration of smoking. For blood biochemistry analyses, total cholesterol (T-C), triglyceride (TG) and HDL cholesterol (HDL-C), uric acid and CRP were measured under fasting conditions within 24 hours after admission. LDL cholesterol (LDL-C) was calculated using the Friedewald formula 25) : T-C (mg/dL) HDL-C (mg/dL) 0.2 TG (mg/dL), for patients with less than 400 mg/dL of TG, or T-C (mg/dL) HDL-C (mg/dL) 0.16 TG (mg/dL), for patients with 400 mg/dL of TG or higher (2 cases). CRP levels were measured using a latex particle-enhanced immunoassay (Nitto Boseki Co. Ltd., Tokyo, Japan), with coeffi-cients of variation (CVs) of 5%, and a lower measurement threshold of 0.02 mg/dL. To investigate the relation between CRP and various factors, subjects were divided into four groups based on the quartile of CRP (CRP-1, 0-0.04 mg/dL; CRP-2, 0.05-0.14 mg/ dL; CRP-3, 0.15-0.45 mg/dL; CRP-4, 0.46-1.98 mg/ dL). The history of antihypertensive and/or antilipidemic drug use was also evaluated. The presence or absence of diabetes mellitus was diagnosed at the first examination using 75 g oral glucose tolerance test. Patients who had previously been treated for diabetes mellitus were also defined as diabetic.
Statistical Analysis
Statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). Differences among the four groups divided based on CRP were analyzed by Mann-Whitney U-test or 2 -test. Correlations between various characteristics and IMT were made using Spearman's correlation test. The relation between risk factors including CRP and IMT was examined by stepwise multiple regression analysis. A general linear model was employed to evaluate the significance of CRP as a risk factor for IMT. A value of p 0.05 was considered significant. Table 1 shows the background characteristics of the four groups stratified by CRP levels. Several characteristics differed among the quartiles of distribution of CRP, and age (p 0.026), visceral obesity (p 0.023), smoking (p 0.049) and uric acid (p 0.016) tended to have higher values in groups with higher CRP. There were no inter-group differences in sex, BMI, SBP, DBP, antihypertensive drug use, LDL-C, HDL-C, antilipidemic drug use, blood glucose, presence of diabetes mellitus or the presence of atherosclerotic disease. Plus-minus values indicate the means standard deviation. Body mass index was calculated using weight in kilograms divided by the square of height in meters. Patients with a history of upper abdominal surgery were excluded to avoid any possible effect on the measurement of fat thickness (CRP-1, N 7; CRP-2, N 12; CRP-3, N 9; CRP-4, N 10). Smoking status: daily consumption (packs) duration of smoking (years). Ischemic stroke included transient ischemic attack and cerebral infarction, and ischemic heart disease included angina pectoris and myocardial infarction. 
Results
Characteristics of Patients in Quartiles of C-reactive Protein
Carotid Atherosclerosis According to Serum C-reactive Protein Level
Carotid IMT values were significantly higher in groups with higher CRP (p 0.022), and carotid IMT in the third highest CRP group (p 0.007) and the fourth highest CRP groups (p 0.013) were significantly higher than those in the lowest group. In the fourth highest CRP group, the prevalence of patients with carotid plaque was also significantly greater than that in the lowest group (p 0.013). Table 3 shows the correlation coefficient between the background characteristics and carotid IMT by CRP level. In all subjects, age (p 0.001), SBP (p 0.001), antihypertensive drug use (p 0.001), LDL-C (p 0.013), uric acid (p 0.039), and CRP (p 0.007) were significantly correlated with IMT. To identify the possible CRP level and risk factor interactions for IMT, Spearman's correlation test for IMT was performed using risk factors in the lower CRP groups (CRP-1 CRP-3) and in the highest CRP group (CRP-4). Similar relations were found between several characteristics and IMT; however, it was shown that uric acid was not significantly associated with IMT in the lower CRP groups, and LDL-C was not associated with IMT in the highest CRP group, but the presence of diabetes mellitus was significantly associated with IMT in the highest CRP group (p 0.001).
Correlation between Various Characteristics and Carotid Intima-media Thickness by C-reactive Protein Level
Association between Various Characteristics and Carotid Intima-media Thickness as Determined by Multiple Linear Regression Analysis
To determine whether the CRP level interacts with other risk factors for IMT, multiple regression analysis for IMT was performed with risk factors in subjects with a specific CRP level ( Table 4 ). It was shown that age, smoking status, SBP and LDL-C were significantly associated with IMT in subjects in the lower CRP groups (CRP-1 CRP-3), and age, SBP and presence of diabetes mellitus in the highest CRP group (CRP-4). Smoking status, LDL-C and presence of diabetes mellitus also significantly differed between subjects in the lower CRP groups and those in the highest CRP group ( Table 4) . Analysis of covariance showed that the regression line between CRP and IMT was significantly different between subjects with diabetes mellitus and those without (CRP diabetes mellitus F 2.708; p 0.045) (Fig. 1) ; however, it was shown that interactions among smoking status and LDL-C and CRP were not significantly associated with carotid IMT.
Risk Factor-CRP Interaction for IMT
To further investigate whether the interaction between CRP and conventional risk factor could influence IMT, a general linear model for IMT was analyzed with the following parameters: sex, age, SBP, antihypertensive drug use, LDL-C, HDL-C, presence of diabetes mellitus and CRP including interactions between CRP and LDL-C and the presence of diabetes mellitus ( Table 5) . It was shown that interaction between CRP and the presence of diabetes mellitus (F 4.754 p 0.030) was significantly associated with IMT, in addition to sex, age, SBP, antihypertensive drug use, LDL-C and HDL-C. This finding indicates that the association between CRP and IMT significantly differed between subjects with and without diabetes mellitus. 
Discussion
This study examined the association between CRP and carotid IMT and plaque in patients with risk factors, and demonstrated that carotid IMT and the prevalence of carotid plaque were significantly higher in groups with higher CRP. Multivariate analysis demonstrated that the association between CRP and carotid IMT was independent of other risk factors, such as age, sex, smoking status, hypertension, LDL-C and diabetes mellitus. Furthermore, we also demonstrated an interaction between the presence of diabetes mellitus and CRP level on carotid IMT.
Many studies have demonstrated that measures of obesity (BMI), smoking status, markers of visceral obesity, uric acid, and other variables related to metabolic syndrome were strongly associated with CRP 16, 26, 27) . In a Japanese longitudinal study of the relation between the development of atherosclerotic lesions and CRP, the CRP concentration was shown to be a marker of carotid atherosclerotic activity rather than the extent of atherosclerosis during the early stages of carotid atherosclerosis 17) . Several studies have shown that the plaque score increased significantly with increasing CRP quartile (p 0.01) even after adjustment for age and other traditional risk factors in men 28) , and multivariate-adjusted odds ratios for carotid stenosis ( 25%) remained significant for women 29) . Although the role of CRP as an independent risk factor for carotid atherosclerosis remains controversial, a recent study in a population at high risk for cardiovascular disease suggested that CRP was not significantly associated with IMT or the presence of coronary artery calcium 15) . In a cross-sectional study of 820 healthy Korean adult volunteers (35-79 years old), higher CRP quartile groups had higher mean carotid IMT, as compared with the lowest quartile (p 0.001 for the trend across quartiles); however, after adjusting for cardiovascular risk factors, no significant association was observed 14) . Differences in these studies may be due to the study population, the prevalence of subjects with specific disease conditions, and/or the site and method of carotid measurement.
One hypothesis explaining our results is that increases in CRP concentrations are related to adipose tissue-derived cytokines 30) . The relationship may thus be due to the association of BMI with both insulin resistance and the acute-phase response. Experimental studies indicate that adipose tissue produces tumor necrosis factor (TNF)- 31) . TNF-induces interleukin-6 (IL-6) synthesis, a regulator of CRP synthesis, and TNF-also induces hyperinsulinemia, an indirect measure of insulin resistance 31) . We found that CRP was related to visceral obesity measured by ultrasonography rather than BMI. This relationship suggests that visceral fat accumulation is important in inducing inflammation and mediating metabolic syndrome. Increased CRP has also been reported in diabetes 32) . There are several mechanisms by which a low degree of inflammation might be induced in diabetes. Serum concentration of advanced glycation end products (AGEs) is increased in patients with diabetes and is an independent determinant of plasma CRP levels. Subclinical inflammation in these patients may therefore be partly due to activation of the inflammatory response such as upregulating the synthesis of interleukin-1, interleukin-6, and TNF-, by AGEs 33) . In this study, our observation of an association between CRP and carotid atherosclerosis is consistent with these findings; however, the non-significant relationship between CRP and carotid atherosclerosis observed to date does not contradict this theory. One reason may be marked differences in the risk factors of various subjects because individuals with an elevated CRP develop carotid atherosclerosis under conditions of diabetes mellitus. In most studies, it was not considered whether different risk factor-CRP interaction could be involved in the etiology of carotid atherosclerosis. In contrast, in our study, diabetes mellitus as well as age and SBP were significant predictors of carotid atherosclerosis only in subjects with elevated CRP.
Another finding of some studies was that CRP may reflect low-grade inflammation due to disease processes including infections 34) , smoking 16) and obe- The net effect of each interaction was estimated using a general linear model including each confounding factor, and the interaction between C-reactive protein and history of diabetes mellitus. Body mass index was calculated using weight in kilograms divided by the square of height in meters. The interaction between C-reactive protein and history of diabetes mellitus and LDL-cholesterol. sity 11, 16, 30) . These findings suggest that CRP may also serve as a complementary and quantitative marker of atherosclerotic formation rather than a risk factor 28) . The interaction between CRP and diabetes mellitus in our study might reflect the level of infection in diabetes mellitus. Moreover, it is conceivable that diabetic patients have more risk factors inducing low-grade inflammatory conditions, such as status of glucose control and microangiopathic complications.
We need to be aware of various limitations when interpreting these results. First, since all participants were hospitalized, we could not eliminate the possibility of effects from underlying diseases, especially infection. CRP was assessed from one blood sample, but none of the subjects had a CRP level greater than 2.0 mg/dL, the cut-off point generally used to indicate clinically relevant infection. Secondly, we could not eliminate the possible effect of medication for hypertension and dislipidemia on these findings. Antihypertensive drug use varied from 54.5% in subjects in the lower CRP groups (CRP-1 3), to 52.6% in subjects in the highest CRP group (CRP-4). However, effects of lipid medication are unlikely because only 10.6% of those in the lower CRP groups and 6.6% of those in the higher CRP group received lipid-lowering treatment. Thirdly, these data were obtained from a crosssectional study, thereby precluding temporality and casual inference. However, there are also some advantages of this study design that are worth noting. First, we were able to examine an extensive array of atherosclerotic risk factors in relation to CRP. Second, noninvasive ultrasound imaging of carotid IMT provided a direct measurment of atheroma development. These points need to be addressed again in a prospective fashion using a large population-based sample.
In conclusion, we propose that CRP may be a risk factor or marker for ultrasonographically determined carotid atherosclerosis.
